NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Wednesday that its first-quarter revenues increased 16 percent, while the firm cut its net loss significantly on lower charges year over year.

The Alameda, Calif.-based molecular diagnostics firm generated revenues of $45.7 million for the three-month period ended March 28, compared to revenues of $39.5 million for the first quarter of 2008.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.